Our founders build at the convergence of data and science in health and sustainability
Predictive agriculture, using machine learning to track and quantify soil carbon data in real time and field conditions ahead of time
Developing quantum photonic hardware for cybersecurity and quantum networking applications
Fighting infectious disease with AI, genomics, and developing the leading microbial sequence database
Novel hydrogel platform developing ADAM™, the world’s first implant designed to provide men with long-lasting, reversible contraception.
Creating the largest and highest-fidelity AI training platform for clinical AI product developers
Photonic-electronic Design IP, chiplets and custom silicon for computing, self-driving cars, industrial automation and medtech
High performance, sustainable composite materials for buildings, electronics, mobility, and defense
On-body sensors and AI for objective, accurate musculoskeletal (MSK) diagnosis and monitoring
Leading AI team applying LLMs to design novel base editors and gene editing enzymes to be used in drug discovery
Connected devices for steam trap monitoring, with the goal of optimizing fuel consumption and improving safety in industrial plants
Ultrasound medical device producing MRI quality data on liver health
Targeted drug delivery
Diagnostic testing for liver disease
Innovative image sensors paired with computer vision algorithms that can be used to directly analyze data streams, reconfiguring the way computers “see” data
Wavefront sensor technology for vision analysis and correction
EXITS
Antigen/antibody discovery platform based on applying machine learning to high-responder patient samples
Acquired (NASDAQ: ABSI)
Next-generation AI platform for drug discovery and optimization spun out from MILA